Free Trial
→ The Fed Just Got Kneecapped — Here’s What Happens Next (From Banyan Hill Publishing) (Ad)tc pixel Free BDRX Stock Alerts

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$6.35 -0.26 (-3.93%)
Closing price 03:59 PM Eastern
Extended Trading
$6.65 +0.30 (+4.72%)
As of 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Biodexa Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
09/12/2025
8:00 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/12/2025
8:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/12/2025
8:13 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/12/2025
8:16 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/18/2025
8:28 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/18/2025
8:29 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/18/2025
8:29 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/18/2025
7:31 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/31/2025
8:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/18/2025
4:23 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/18/2025
4:23 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/18/2025
4:23 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:15 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:16 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/27/2025
4:16 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/13/2025
3:19 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/04/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/02/2025
4:23 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
06/02/2025
4:24 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/30/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/28/2025
4:59 PM		Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
05/22/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/15/2025
4:16 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/15/2025
4:16 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
7:31 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/11/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/11/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
05/12/2025
5:02 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
05/12/2025
5:02 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
04/29/2025
3:15 PM		Biodexa Pharmaceuticals (Filer)
Form POS AM
04/17/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:41 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:43 AM		Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
3:30 PM		Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
02/13/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/22/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:27 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:30 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:21 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:24 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/17/2025
3:49 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/17/2025
3:21 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
12/27/2024
4:15 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:56 AM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BDRX) was last updated on 9/26/2025 by MarketBeat.com Staff
From Our Partners
Why More Investors Are Using Family Trusts to Protect Their Wealth
For many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...
SmartAsset | Sponsoredtc pixel
What The Silver Boom Could Mean For You…
AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...
Goldco Precious Metals | Sponsoredtc pixel
Claim Your Share of $5.39 BILLION in AI Equity Checks
The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...
Angel Publishing | Sponsoredtc pixel
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Nvidia Times 1,000,000
Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...
Paradigm Press | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...
American Alternative | Sponsoredtc pixel
Forget Tesla — This Tiny AI Stock Is Musk’s Real Play
While Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...
Behind the Markets | Sponsoredtc pixel